| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 10 | 2024 | 554 | 2.850 |
Why?
|
| Mammary Glands, Animal | 9 | 2023 | 533 | 2.170 |
Why?
|
| Metal Nanoparticles | 4 | 2024 | 164 | 1.250 |
Why?
|
| Mammary Neoplasms, Experimental | 5 | 2023 | 494 | 1.160 |
Why?
|
| Nanostructures | 3 | 2020 | 94 | 0.940 |
Why?
|
| Cerium | 2 | 2024 | 3 | 0.930 |
Why?
|
| Wound Infection | 1 | 2022 | 54 | 0.850 |
Why?
|
| Genetic Vectors | 4 | 2020 | 1694 | 0.840 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2018 | 221 | 0.830 |
Why?
|
| Gadolinium | 3 | 2020 | 164 | 0.820 |
Why?
|
| Chlorine | 1 | 2020 | 15 | 0.770 |
Why?
|
| Free Radicals | 1 | 2020 | 62 | 0.760 |
Why?
|
| Gene Editing | 1 | 2023 | 216 | 0.760 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 2864 | 0.750 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 71 | 0.740 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 7702 | 0.730 |
Why?
|
| Energy Transfer | 1 | 2019 | 35 | 0.720 |
Why?
|
| Thermography | 1 | 2020 | 59 | 0.720 |
Why?
|
| Epithelial Cells | 7 | 2024 | 1818 | 0.710 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2019 | 8 | 0.700 |
Why?
|
| Glutathione | 3 | 2023 | 368 | 0.700 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2018 | 122 | 0.690 |
Why?
|
| Carcinogenesis | 6 | 2021 | 1026 | 0.680 |
Why?
|
| Lentivirus | 5 | 2020 | 169 | 0.660 |
Why?
|
| Wnt Signaling Pathway | 3 | 2021 | 430 | 0.640 |
Why?
|
| Neoplasms | 5 | 2024 | 15193 | 0.600 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 374 | 0.590 |
Why?
|
| Oncogenes | 4 | 2024 | 673 | 0.580 |
Why?
|
| DNA Helicases | 1 | 2019 | 434 | 0.570 |
Why?
|
| Mice | 30 | 2024 | 34495 | 0.550 |
Why?
|
| Transfection | 2 | 2020 | 2944 | 0.540 |
Why?
|
| Precancerous Conditions | 2 | 2023 | 1058 | 0.540 |
Why?
|
| Animals | 37 | 2024 | 59536 | 0.540 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2018 | 2359 | 0.510 |
Why?
|
| Stem Cells | 3 | 2021 | 1213 | 0.510 |
Why?
|
| RNA, Ribosomal | 2 | 2012 | 83 | 0.510 |
Why?
|
| Oxygen | 1 | 2018 | 754 | 0.490 |
Why?
|
| Gene Transfer Techniques | 2 | 2023 | 716 | 0.460 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 598 | 0.460 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2013 | 11 | 0.450 |
Why?
|
| Insecta | 1 | 2013 | 76 | 0.440 |
Why?
|
| Heteroptera | 1 | 2012 | 10 | 0.420 |
Why?
|
| Archaea | 1 | 2012 | 18 | 0.420 |
Why?
|
| Eukaryota | 1 | 2012 | 27 | 0.420 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 3343 | 0.400 |
Why?
|
| Wnt Proteins | 1 | 2013 | 397 | 0.400 |
Why?
|
| Ribosomes | 1 | 2012 | 147 | 0.390 |
Why?
|
| Receptor, ErbB-2 | 4 | 2016 | 2518 | 0.360 |
Why?
|
| Retroviridae | 3 | 2023 | 332 | 0.350 |
Why?
|
| Silicon Dioxide | 3 | 2020 | 50 | 0.340 |
Why?
|
| Breast Neoplasms | 9 | 2021 | 15694 | 0.330 |
Why?
|
| Mice, Transgenic | 8 | 2023 | 4143 | 0.330 |
Why?
|
| Protein Array Analysis | 2 | 2022 | 501 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 8873 | 0.300 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 7222 | 0.290 |
Why?
|
| Skin Neoplasms | 2 | 2020 | 4654 | 0.270 |
Why?
|
| Transcription Factors | 1 | 2019 | 5270 | 0.250 |
Why?
|
| Antineoplastic Agents | 5 | 2020 | 14289 | 0.240 |
Why?
|
| Benzopyrans | 1 | 2024 | 41 | 0.240 |
Why?
|
| Genes, Reporter | 4 | 2020 | 798 | 0.240 |
Why?
|
| Rats | 2 | 2024 | 6086 | 0.230 |
Why?
|
| Peptidoglycan | 1 | 2022 | 14 | 0.230 |
Why?
|
| Boron | 1 | 2022 | 10 | 0.230 |
Why?
|
| Hydrogen Peroxide | 3 | 2023 | 217 | 0.220 |
Why?
|
| Recombinational DNA Repair | 1 | 2023 | 79 | 0.220 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 615 | 0.220 |
Why?
|
| Proteogenomics | 1 | 2023 | 87 | 0.220 |
Why?
|
| beta Catenin | 3 | 2023 | 688 | 0.220 |
Why?
|
| Particle Size | 2 | 2020 | 182 | 0.220 |
Why?
|
| Surface Properties | 2 | 2020 | 180 | 0.220 |
Why?
|
| Boron Compounds | 1 | 2022 | 59 | 0.220 |
Why?
|
| Microbubbles | 1 | 2022 | 14 | 0.210 |
Why?
|
| CD40 Ligand | 1 | 2022 | 115 | 0.210 |
Why?
|
| Cell Line, Tumor | 13 | 2023 | 14551 | 0.210 |
Why?
|
| Acoustics | 1 | 2022 | 42 | 0.210 |
Why?
|
| Melanoma | 1 | 2019 | 5317 | 0.210 |
Why?
|
| Electric Impedance | 1 | 2022 | 100 | 0.200 |
Why?
|
| Nucleic Acid Conformation | 2 | 2013 | 279 | 0.200 |
Why?
|
| Rats, Transgenic | 1 | 2020 | 21 | 0.200 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 566 | 0.190 |
Why?
|
| Temperature | 2 | 2020 | 506 | 0.190 |
Why?
|
| Drug Carriers | 2 | 2023 | 327 | 0.190 |
Why?
|
| Neuroprotection | 1 | 2020 | 19 | 0.190 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2020 | 23 | 0.190 |
Why?
|
| Silver | 1 | 2020 | 34 | 0.190 |
Why?
|
| Infrared Rays | 1 | 2020 | 54 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 534 | 0.190 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 83 | 0.190 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 64 | 0.190 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 558 | 0.180 |
Why?
|
| Sodium Fluoride | 1 | 2020 | 30 | 0.180 |
Why?
|
| Female | 25 | 2023 | 141928 | 0.180 |
Why?
|
| Keratin-6 | 3 | 2016 | 39 | 0.180 |
Why?
|
| Phylogeny | 2 | 2013 | 826 | 0.180 |
Why?
|
| CRISPR-Cas Systems | 1 | 2023 | 323 | 0.180 |
Why?
|
| Bismuth | 1 | 2020 | 75 | 0.180 |
Why?
|
| Cell Survival | 4 | 2020 | 3045 | 0.180 |
Why?
|
| Theranostic Nanomedicine | 2 | 2017 | 14 | 0.170 |
Why?
|
| Metformin | 1 | 2023 | 378 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2992 | 0.170 |
Why?
|
| Spine | 1 | 2020 | 293 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 11538 | 0.170 |
Why?
|
| A549 Cells | 1 | 2018 | 124 | 0.160 |
Why?
|
| Wnt1 Protein | 1 | 2018 | 103 | 0.160 |
Why?
|
| Plasmids | 1 | 2020 | 837 | 0.160 |
Why?
|
| Thiazoles | 1 | 2023 | 726 | 0.160 |
Why?
|
| Bacteria | 1 | 2022 | 611 | 0.160 |
Why?
|
| HEK293 Cells | 2 | 2020 | 1489 | 0.160 |
Why?
|
| Sepsis | 1 | 2024 | 652 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2013 | 1113 | 0.160 |
Why?
|
| Cell Nucleus | 1 | 2023 | 1620 | 0.160 |
Why?
|
| Magnetic Fields | 1 | 2018 | 31 | 0.160 |
Why?
|
| Copper | 1 | 2018 | 165 | 0.160 |
Why?
|
| Cysteine | 1 | 2018 | 214 | 0.160 |
Why?
|
| Naphthoquinones | 1 | 2017 | 18 | 0.150 |
Why?
|
| Bayes Theorem | 2 | 2013 | 1021 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 336 | 0.150 |
Why?
|
| Computational Biology | 3 | 2014 | 1271 | 0.150 |
Why?
|
| Cell Proliferation | 7 | 2020 | 7226 | 0.150 |
Why?
|
| Spleen | 1 | 2019 | 676 | 0.150 |
Why?
|
| Wound Healing | 1 | 2022 | 815 | 0.150 |
Why?
|
| Adenoviridae | 1 | 2023 | 1459 | 0.150 |
Why?
|
| Cell Plasticity | 1 | 2017 | 66 | 0.150 |
Why?
|
| Twist-Related Protein 1 | 1 | 2017 | 127 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 624 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2020 | 703 | 0.150 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 2086 | 0.140 |
Why?
|
| Humans | 24 | 2023 | 261506 | 0.140 |
Why?
|
| Iron Compounds | 1 | 2016 | 2 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 1443 | 0.140 |
Why?
|
| Inflammation | 2 | 2024 | 2522 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 973 | 0.140 |
Why?
|
| Base Sequence | 2 | 2013 | 4917 | 0.130 |
Why?
|
| Hyperthermia, Induced | 2 | 2018 | 510 | 0.130 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 198 | 0.130 |
Why?
|
| X-Rays | 1 | 2015 | 146 | 0.130 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 6089 | 0.130 |
Why?
|
| Claudins | 1 | 2014 | 47 | 0.130 |
Why?
|
| Histones | 1 | 2022 | 1466 | 0.130 |
Why?
|
| Tungsten Compounds | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cell Movement | 2 | 2019 | 2466 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 21 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2020 | 1129 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 3981 | 0.120 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 1341 | 0.120 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 931 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 2314 | 0.110 |
Why?
|
| Phototherapy | 1 | 2013 | 75 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 336 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 217 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 519 | 0.110 |
Why?
|
| DNA, Ribosomal | 1 | 2013 | 103 | 0.110 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2012 | 33 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 4821 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 166 | 0.110 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 852 | 0.110 |
Why?
|
| Iron | 1 | 2016 | 376 | 0.110 |
Why?
|
| Peptidyl Transferases | 1 | 2012 | 6 | 0.110 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2012 | 25 | 0.110 |
Why?
|
| Contig Mapping | 1 | 2012 | 61 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2013 | 137 | 0.110 |
Why?
|
| Thyroid Hormones | 1 | 2012 | 111 | 0.100 |
Why?
|
| Base Pairing | 1 | 2012 | 68 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2018 | 5637 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2012 | 233 | 0.100 |
Why?
|
| Conserved Sequence | 1 | 2013 | 469 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2015 | 644 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2013 | 185 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 2488 | 0.100 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 679 | 0.100 |
Why?
|
| Gene Amplification | 1 | 2014 | 731 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2013 | 844 | 0.100 |
Why?
|
| Liver | 1 | 2019 | 2961 | 0.090 |
Why?
|
| Oxidation-Reduction | 2 | 2023 | 717 | 0.090 |
Why?
|
| Phosphorylation | 4 | 2024 | 4804 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 671 | 0.080 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2008 | 110 | 0.080 |
Why?
|
| Mice, Nude | 4 | 2018 | 4307 | 0.080 |
Why?
|
| I-kappa B Kinase | 2 | 2024 | 250 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 621 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 1121 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2018 | 4078 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 834 | 0.080 |
Why?
|
| Binding Sites | 1 | 2012 | 2171 | 0.080 |
Why?
|
| Chromatin | 2 | 2023 | 942 | 0.080 |
Why?
|
| Neoplasm Transplantation | 3 | 2014 | 1519 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 3578 | 0.070 |
Why?
|
| Cisplatin | 1 | 2013 | 2432 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2012 | 1549 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2012 | 1203 | 0.070 |
Why?
|
| Keratins | 1 | 2006 | 330 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2020 | 11965 | 0.060 |
Why?
|
| Software | 1 | 2012 | 1321 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2576 | 0.060 |
Why?
|
| Apoptosis | 5 | 2021 | 7591 | 0.060 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 1215 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2012 | 2022 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 5437 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2012 | 2295 | 0.060 |
Why?
|
| Polyphenols | 1 | 2023 | 29 | 0.060 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2023 | 112 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2018 | 1869 | 0.050 |
Why?
|
| Electrons | 1 | 2023 | 168 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 694 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2012 | 2819 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 1823 | 0.050 |
Why?
|
| DNA Damage | 1 | 2010 | 1954 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2012 | 1797 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 3552 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 376 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 557 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 2045 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 521 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4557 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2013 | 575 | 0.050 |
Why?
|
| Dioxygenases | 1 | 2020 | 159 | 0.040 |
Why?
|
| Hydroxyl Radical | 1 | 2018 | 19 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 5178 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2017 | 5710 | 0.040 |
Why?
|
| Doxorubicin | 2 | 2018 | 3005 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 621 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 987 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 3821 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 575 | 0.040 |
Why?
|
| Time Factors | 1 | 2012 | 12926 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 803 | 0.040 |
Why?
|
| Luminescent Agents | 1 | 2017 | 18 | 0.040 |
Why?
|
| Osteocytes | 1 | 2017 | 27 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2020 | 388 | 0.040 |
Why?
|
| Ferric Compounds | 1 | 2018 | 73 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 208 | 0.040 |
Why?
|
| Intestines | 1 | 2021 | 686 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 905 | 0.040 |
Why?
|
| Glass | 1 | 2016 | 30 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2017 | 157 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 2054 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 4849 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 7789 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1493 | 0.030 |
Why?
|
| Male | 3 | 2021 | 123000 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 1399 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 585 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 1130 | 0.030 |
Why?
|
| Virus Latency | 1 | 2015 | 78 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 38 | 0.030 |
Why?
|
| Fluorescence | 1 | 2014 | 195 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 550 | 0.030 |
Why?
|
| Virion | 1 | 2015 | 161 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 59 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2015 | 214 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 222 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 249 | 0.030 |
Why?
|
| Materials Testing | 1 | 2013 | 116 | 0.030 |
Why?
|
| Organosilicon Compounds | 1 | 2013 | 3 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2013 | 43 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2013 | 33 | 0.030 |
Why?
|
| Colloids | 1 | 2013 | 34 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 3101 | 0.030 |
Why?
|
| Porosity | 1 | 2013 | 56 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 328 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 205 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 669 | 0.030 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2012 | 36 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 54 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 475 | 0.030 |
Why?
|
| Adult | 1 | 2019 | 77950 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 55 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2013 | 189 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 667 | 0.030 |
Why?
|
| Middle Aged | 1 | 2019 | 86204 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 184 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 663 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 870 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2013 | 339 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 733 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 611 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 388 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 423 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 305 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1077 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 6942 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 1643 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2020 | 2669 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 519 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 703 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2014 | 1944 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 1764 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 6682 | 0.020 |
Why?
|
| Keratin-9 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Alpharetrovirus | 1 | 2008 | 7 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 12873 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 2232 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 1538 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2008 | 138 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 1408 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 260 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 1742 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 430 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2010 | 382 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 4938 | 0.020 |
Why?
|
| HIV | 1 | 2008 | 229 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2014 | 1682 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 1248 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 2450 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8865 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 5114 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 3254 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 286 | 0.020 |
Why?
|
| Mutation | 2 | 2016 | 15179 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 6009 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 1498 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 7551 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 21713 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 5159 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 32848 | 0.010 |
Why?
|